Incyte Stock Buy Hold or Sell Recommendation

INCY -  USA Stock  

USD 73.52  0.63  0.85%

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Incyte Corp is 'Strong Buy'. Macroaxis provides Incyte Corp buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding INCY positions. The advice algorithm takes into account all of Incyte Corp's available fundamental, technical, and predictive indicators you will find on this site.

Incyte Advice 

The advice is provided from Incyte Corp's buy-and-hold perspective. Please see Incyte Corp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Incyte and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Incyte Corp.

Execute Incyte Corp Buy or Sell Advice

The Incyte recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Incyte Corp. Macroaxis does not own or have any residual interests in Incyte Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Incyte Corp's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Incyte CorpBuy Incyte Corp
Strong Buy


Very steadyDetails

Hype Condition

Under hypedDetails

Current Valuation


Odds of Distress

Below AverageDetails

Economic Sensitivity

Slowly supersedes the marketDetails

Analyst Consensus


Financial Strenth (F Score)


Financial Leverage


Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Incyte Corp has a Risk Adjusted Performance of 0.0837, Jensen Alpha of 0.2177, Total Risk Alpha of 0.3582, Sortino Ratio of 0.1079 and Treynor Ratio of 0.4907
Macroaxis provides unbiased trade recommendations on Incyte Corp that should be used to complement current analysts and expert consensus on Incyte Corp. Our advice engine determines the entity's potential to grow exclusively from the perspective of an investors' current risk tolerance and investing horizon. To make sure Incyte Corp is not overpriced, please check out all Incyte Corp fundamentals, including its shares owned by institutions, debt to equity, working capital, as well as the relationship between the gross profit and price to earnings to growth . Given that Incyte Corp has a number of shares shorted of 4.56 M, we strongly advise you to confirm Incyte Corp market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Incyte Corp Trading Alerts and Improvement Suggestions

Incyte Corp has a frail financial position based on the latest SEC disclosures
Over 94.0% of the company shares are owned by institutional investors
Latest headline from INCY Incyte Provides Update On Parsaclisib And Mcla-145 - CML News

Incyte Corp current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Incyte analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Incyte analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price92.25
Target Median Price92.50
Target High Price136.00
Recommendation Mean2.10
Number Of Analyst Opinions16
Target Low Price66.00
Average Consensus Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Incyte Corp Returns Distribution Density

The distribution of Incyte Corp's historical returns is an attempt to chart the future uncertainty of Incyte Corp's future price movements. The chart of the probability distribution of Incyte Corp stock daily returns describes the distribution of returns around its average expected value. We use Incyte Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Incyte Corp returns is essential to provide solid investment advice for Incyte Corp stock.
Mean Return0.20Value At Risk-2.92
Potential Upside3.69Standard Deviation2.16
 Return Density 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Incyte Corp historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Incyte Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Incyte Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Incyte Corp backward and forwards among themselves. Incyte Corp's institutional investor refers to the entity that pools money to purchase Incyte Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Russell Investments Group LtdCommon Shares282.6 K20.7 M
Australiansuper Pty LtdCommon Shares279.8 K20.1 M
New York State Teachers Retirement SystemCommon Shares232.6 K17.1 M
Retirement Systems Of AlabamaCommon Shares197.6 K14.5 M
Exchange Traded Concepts LlcCommon Shares84.9 K6.2 M
Frontier Capital Management Co Llc 1Common Shares78.7 K5.8 M
Key Financial IncCommon Shares65.5 K4.8 M
Note, although Incyte Corp's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Incyte Corp Cash Flow Accounts

201720182019202020212022 (projected)
Capital Expenditure(111.02 M)(73.48 M)(78.06 M)(187.38 M)(168.64 M)(173.08 M)
Depreciation Amortization and Accretion52.18 M54.97 M54.53 M51.81 M59.58 M57.08 M
Net Cash Flow or Change in Cash and Cash Equivalents247.21 M264.55 M668.72 M(318.94 M)(366.78 M)(376.44 M)
Issuance Purchase of Equity Shares716.15 M29.94 M63.3 M110.31 M126.85 M141.41 M
Net Cash Flow from Financing690.21 M14.66 M45.71 M71.71 M82.47 M123.73 M
Net Cash Flow from Investing(349.98 M)(86.42 M)(87.45 M)(269 M)(242.1 M)(248.47 M)
Net Cash Flow Investment Acquisitions and Disposals(238.96 M)(12.94 M)(9.39 M)(81.62 M)(73.46 M)(79.26 M)
Net Cash Flow from Operations(92.99 M)336.23 M710.66 M(124.6 M)(143.29 M)(147.06 M)
Effect of Exchange Rate Changes on Cash(39 K)91 K(192 K)2.95 M3.39 M3.66 M
Share Based Compensation133.06 M148.15 M166.59 M177.88 M204.56 M163.22 M

Incyte Corp Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Incyte Corp or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Incyte Corp stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Incyte stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over DOW
Beta against DOW0.39
Overall volatility
Information ratio 0.12

Incyte Corp Volatility Alert

Incyte Corp currently demonstrates below-average downside deviation. It has Information Ratio of 0.12 and Jensen Alpha of 0.22. However, we advise investors to further question Incyte Corp expected returns to ensure all indicators are consistent with the current outlook about its relatively low value at risk. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Incyte Corp's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Incyte Corp's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Incyte Corp Implied Volatility

Incyte Corp's implied volatility exposes the market's sentiment of Incyte Corp stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Incyte Corp's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Incyte Corp stock will not fluctuate a lot when Incyte Corp's options are near their expiration.

Incyte Corp Fundamentals Vs Peers

Comparing Incyte Corp's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Incyte Corp's direct or indirect competition across all of the common fundamentals between Incyte Corp and the related equities. This way, we can detect undervalued stocks with similar characteristics as Incyte Corp or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Incyte Corp's fundamental indicators could also be used in its relative valuation, which is a method of valuing Incyte Corp by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare Incyte Corp to competition
FundamentalsIncyte CorpPeer Average
Return On Equity19.30 %(0.31) %
Return On Asset10.90 %(0.14) %
Profit Margin18.35 %(1.27) %
Operating Margin22.47 %(5.51) %
Current Valuation13.64 B16.62 B
Shares Outstanding220.89 M571.82 M
Shares Owned by Insiders1.51 %10.09 %
Shares Owned by Institutions93.85 %39.21 %
Number of Shares Shorted4.56 M4.71 M
Price to Earning31.01 X28.72 X
Price to Book5.25 X9.51 X
Price to Sales5.67 X11.42 X
Revenue2.91 B9.43 B
Gross Profit276.63 M27.38 B
EBITDA713.3 M3.9 B
Net Income534.58 M570.98 M
Cash and Equivalents2.28 B2.7 B
Cash per Share10.34 X5.01 X
Total Debt58.58 M5.32 B
Debt to Equity0.018 %48.70 %
Current Ratio3.94 X2.16 X
Book Value Per Share14.26 X1.93 K
Cash Flow from Operations741.46 M971.22 M
Short Ratio1.92 X4.00 X
Earnings Per Share2.41 X3.12 X
Price to Earnings To Growth1.37 X4.89 X
Number of Employees1.77 K18.84 K
Market Capitalization16.52 B19.03 B
Total Asset1.01 B29.47 B
Retained Earnings(1.54 B)9.33 B
Working Capital674.37 M1.48 B
Current Asset842.38 M9.34 B
   Payment of tradable shares by Morrissey Michael James of Incyte Corp subject to Rule 16b-3 [view details]

Incyte Corp Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Incyte . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution78533.09
Daily Balance Of Power(0.32)
Rate Of Daily Change0.99
Day Median Price74.1
Day Typical Price73.91
Market Facilitation Index0.0
Price Action Indicator(0.90)

About Incyte Corp Buy or Sell Advice

When is the right time to buy or sell Incyte Corp? Buying financial instruments such as Incyte Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Incyte Corp investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2019 2020 2021 2022 (projected)
Receivables308.81 M481.99 M433.79 M468.04 M
Inventories11.4 M16.43 M14.78 M15.95 M

Use Investing Ideas to Build Portfolios

In addition to having Incyte Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Commodities Thematic Idea Now

Commodities Theme
Funds or Etfs investing in commodities such as oil, gold, corn, soy, and agricultural goods. Commodities theme has 40 constituents.
View All  Next Launch Commodities
Please see Incyte Corp Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Incyte Corp information on this page should be used as a complementary analysis to other Incyte Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Incyte Stock analysis

When running Incyte Corp price analysis, check to measure Incyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte Corp is operating at the current time. Most of Incyte Corp's value examination focuses on studying past and present price action to predict the probability of Incyte Corp's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Incyte Corp's price. Additionally, you may evaluate how the addition of Incyte Corp to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Is Incyte Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte Corp. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Incyte Corp is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte Corp's value that differs from its market value or its book value, called intrinsic value, which is Incyte Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte Corp's market value can be influenced by many factors that don't directly affect Incyte Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incyte Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine Incyte Corp value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.